HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice.

Abstract
Vaccines that could effectively prevent Pseudomonas aeruginosa pulmonary infections in the settings of cystic fibrosis (CF) and nosocomial pneumonia could be exceedingly useful, but to date no effective immunotherapy targeting this pathogen has been successfully developed for routine use in humans. Evaluations using animals and limited human trials of vaccines and their associated immune effectors against different P. aeruginosa antigens have suggested that antibody to the conserved surface polysaccharide alginate, as well as the flagellar proteins, often give high levels of protection. However, alginate itself does not elicit protective antibody in humans, and flagellar vaccines containing the two predominant serotypes of this antigen may not provide sufficient coverage against variant flagellar types. To evaluate if combining these antigens in a conjugate vaccine would be potentially efficacious, we conjugated polymannuronic acid (PMA), containing the blocks of mannuronic acid conserved in all P. aeruginosa alginates, to type a flagellin (FLA) and evaluated immunogenicity, opsonic killing activity, and passive protective efficacy in mice. The PMA-FLA conjugate was highly immunogenic in mice and rabbits and elicited opsonic antibodies against mucoid but not nonmucoid P. aeruginosa, but nonetheless rabbit antibody to PMA-FLA showed evidence of protective efficacy against both types of this organism in a mouse lung infection model. Importantly, the PMA-FLA conjugate vaccine did not elicit antibodies that neutralized the Toll-like receptor 5 (TLR5)-activating activity of flagellin, an important part of innate immunity to flagellated microbial pathogens. Conjugation of PMA to FLA appears to be a promising path for developing a broadly protective vaccine against P. aeruginosa.
AuthorsVictoria L Campodónico, Nicolas J Llosa, Leticia V Bentancor, Tomas Maira-Litran, Gerald B Pier
JournalInfection and immunity (Infect Immun) Vol. 79 Issue 8 Pg. 3455-64 (Aug 2011) ISSN: 1098-5522 [Electronic] United States
PMID21628521 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Alginates
  • Antibodies, Bacterial
  • Hexuronic Acids
  • Opsonin Proteins
  • Pseudomonas Vaccines
  • Vaccines, Conjugate
  • Flagellin
  • Glucuronic Acid
Topics
  • Alginates (administration & dosage)
  • Animals
  • Antibodies, Bacterial (blood)
  • Female
  • Flagellin (administration & dosage, immunology)
  • Glucuronic Acid (administration & dosage, immunology)
  • Hexuronic Acids (administration & dosage, immunology)
  • Mice
  • Mice, Inbred C3H
  • Mice, Inbred C57BL
  • Opsonin Proteins (blood)
  • Pneumonia, Bacterial (immunology, prevention & control)
  • Pseudomonas Infections (immunology, prevention & control)
  • Pseudomonas Vaccines (administration & dosage, immunology)
  • Pseudomonas aeruginosa (immunology)
  • Rabbits
  • Vaccines, Conjugate (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: